PL Developments Heats Up Private Label Market With Aaron Deal
This article was originally published in The Tan Sheet
Executive Summary
Acquiring liquid product manufacturer Aaron Industries expands solid-dose firm PL Developments’ presence in the field at a time when competition for OTC market share already is fierce. “We think this is a game-changing transaction for us and the industry,” says PL Developments exec Evan Singer.
You may also be interested in...
FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure
Rx-to-OTC switch sponsors should not wait for FDA to act on NSURE before proposing innovative switch solutions, because reviewers are open to discussing ideas now, an agency official says. Some experts predict the new switch paradigm will not yield concrete regulatory changes, and are promoting other ways to expand OTC access.
Major OTC Acquisitions, Expansion Likely In 2014
With major consumer product divisions potentially in play, analysts take a look at possible buyers and sellers in the OTC space. Switches and consumer business expansion plans are also likely to shape 2014.
Major OTC Acquisitions, Expansion Likely In 2014
With major consumer product divisions potentially in play, analysts take a look at possible buyers and sellers in the OTC space. Switches and consumer business expansion plans are also likely to shape 2014.